Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

Toshifumi Yokota, Emidio Pistilli, William Duddy, Kanneboyina Nagaraju

Research output: Contribution to journalArticle

46 Citations (Scopus)
LanguageEnglish
Pages831-842
JournalExpert Opinion on Biological Therapy
Volume7
Issue number6
Publication statusPublished - 2007

Keywords

  • Duchenne muscular dystrophy
  • antisense oligonucleotides
  • morpholinos
  • exon skipping

Cite this

Yokota, Toshifumi ; Pistilli, Emidio ; Duddy, William ; Nagaraju, Kanneboyina. / Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. In: Expert Opinion on Biological Therapy. 2007 ; Vol. 7, No. 6. pp. 831-842.
@article{23963ef915164958aadafd8aad9368fc,
title = "Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy",
keywords = "Duchenne muscular dystrophy, antisense oligonucleotides, morpholinos, exon skipping",
author = "Toshifumi Yokota and Emidio Pistilli and William Duddy and Kanneboyina Nagaraju",
year = "2007",
language = "English",
volume = "7",
pages = "831--842",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
number = "6",

}

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. / Yokota, Toshifumi; Pistilli, Emidio; Duddy, William; Nagaraju, Kanneboyina.

In: Expert Opinion on Biological Therapy, Vol. 7, No. 6, 2007, p. 831-842.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

AU - Yokota, Toshifumi

AU - Pistilli, Emidio

AU - Duddy, William

AU - Nagaraju, Kanneboyina

PY - 2007

Y1 - 2007

KW - Duchenne muscular dystrophy

KW - antisense oligonucleotides

KW - morpholinos

KW - exon skipping

M3 - Article

VL - 7

SP - 831

EP - 842

JO - Expert Opinion on Biological Therapy

T2 - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 6

ER -